Literature DB >> 3361381

Growth and development of infants with end-stage renal disease receiving long-term peritoneal dialysis.

B A Warady1, M Kriley, H Lovell, S E Farrell, S Hellerstein.   

Abstract

The growth and development of four infants with end-stage renal disease receiving long-term peritoneal dialysis was studied during the first year of life. In each patient, dialysis was begun before 4 weeks of age. A nutritional regimen was designed to attain a daily weight gain appropriate for height age while minimizing the blood urea nitrogen level. A neurodevelopmental evaluation of gross and fine motor, cognitive, language, and psychosocial skills was performed at least every 3 months. At age 1 year, the mean height standard deviation score (SDS) was -1.33 +/- 0.2. Weight for height was greater than 95th percentile in one patient and normal in three. Mean caloric and protein intake were 105 +/- 20 kcal/kg/d (11.4 +/- 2.7 kcal/cm/d) and 2.7 g/kg/d (0.30 +/- 0.11 g/cm/d), respectively. Mean blood urea nitrogen was 53.6 +/- 17.8 mg/dL. Developmentally, three of the patients were functioning in the normal range and one was mildly retarded. However, gross motor skills were delayed in all patients. Although infants with end-stage renal disease are usually severely growth retarded and developmentally delayed, our observations suggest that early nutritional intervention and dialysis can yield improved results.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361381     DOI: 10.1016/s0022-3476(88)80687-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

Review 1.  Dialysis therapy in end-stage renal disease.

Authors:  A Kalia
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

2.  Growth of children following the initiation of dialysis: a comparison of three dialysis modalities.

Authors:  B A Kaiser; M S Polinsky; J Stover; B Z Morgenstern; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

3.  Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis.

Authors:  B A Warady; R J Sabath; C A Smith; U Alon; S Hellerstein
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

4.  Growth, development and nutritional status in Japanese children under 2 years on continuous ambulatory peritoneal dialysis.

Authors:  M Honda; Y Kamiyama; K Kawamura; K Kawahara; S Shishido; H Nakai; T Kawamura; H Ito
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

5.  Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis.

Authors:  S P Andreoli; C D Langefeld; S Stadler; P Smith; A Sears; K West
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

6.  The cognitive development of pre-school children treated for chronic renal failure.

Authors:  G M Hulstijn-Dirkmaat; I H Damhuis; M L Jetten; A M Koster; C H Schröder
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

7.  Growth hormone treatment of infants with chronic kidney disease: requirement, efficacy, and safety.

Authors:  Dieter Haffner; Dagmar-Christiane Fischer
Journal:  Pediatr Nephrol       Date:  2009-04-17       Impact factor: 3.714

8.  Vitamin status of infants receiving long-term peritoneal dialysis.

Authors:  B A Warady; M Kriley; U Alon; S Hellerstein
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

9.  Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.

Authors:  F Schaefer; A M Wingen; M Hennicke; S Rigden; O Mehls
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

10.  Early age-dependent growth impairment in chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.

Authors:  J Karlberg; F Schaefer; M Hennicke; A M Wingen; S Rigden; O Mehls
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.